Saolrx is a clinical-stage pharmaceutical brand that aims to create a brighter future in healthcare. Founded in 2015, Saol Therapeutics is driven by a dedicated leadership group who firmly believes that better is always achievable. With a focus on developing new therapies to advance current standard of care treatments, Saol has quickly grown into a robust commercial and clinical development organization with operations worldwide.

Saol has successfully marketed five mature commercial products, received multiple regulatory approvals, and is now solely dedicated to development. Their rapidly growing pipeline includes three late-stage clinical trials, each with multiple near-term catalysts, promising great potential for patients globally. Backed by a committed investor base and a passionate team, Saol Therapeutics is nimble in making strategic decisions and is dedicated to achieving their vision.

With core values based on trustworthiness, patient focus, passion, nimbleness, and entrepreneurship, Saol Therapeutics believes in integrating diverse talents and collaborating with strategic partnerships. They are actively seeking opportunities for partnerships with pharmaceutical and biotechnology companies, as well as academia, to create value and make a meaningful impact in the field of healthcare